Growing up with severe hemophilia: A follow-up study
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study follows up with young adults who have severe hemophilia to learn about their health and life as they grow into adulthood. It aims to understand the challenges they face and what helps them thrive.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently between 20 and 29 years old
- You have severe hemophilia (type A or B)
- You took part in the TRANSHEMO project as a teenager
- You are registered in the FranceCoag registry
- You are willing to participate and have no reading or comprehension difficulties
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the experiences of people with haemophilia, their caregivers, and doctors in Asia and the Pacific. The goal is to understand current care and find ways to improve it. You may be asked about your treatment and daily life.
This study collects information from people with hemophilia about how treatments and daily life affect them. It uses your answers to improve patient-focused care and understand what challenges matter most.
This study looks at how well a newer preventive treatment for hemophilia A works in everyday life. It collects real-world information from patients to help doctors tailor clotting therapy better.
This study looks at how prophylactic treatment for hemophilia affects your daily life, sleep, and feelings about your health. It compares different types of clotting factor concentrates to see if one is easier to manage than the other.
This study looks at the mouth health and quality of life of children with hemophilia. It aims to understand how hemophilia affects oral health so that better dental care can be provided.
This study checks how people with severe hemophilia A are doing over time after joining a previous BioMarin study of BMN 270. It helps researchers understand long-term safety and outcomes and may support your ongoing care plan.
Hear when a new Haemophilia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.